Picato Gel Approved for Actinic Keratoses
LEO Pharma announced that the FDA has approved Picato (ingenol mebutate gel) for the topical treatment of actinic keratosis.
LEO Pharma announced that the FDA has approved Picato (ingenol mebutate gel) for the topical treatment of actinic keratosis.
Merz Aesthetics announced that the FDA has approved Belotero Balance (hyaluronic acid) for the correction of moderate-to-severe facial wrinkles and folds, such as nasolabial folds.
Merz Aesthetics announced that Xeomin (incobotulinumtoxinA) has been approved for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.
Graceway announced that Zyclara (imiquimod) Cream 2.5% has been approved for the treatment of actinic keratosis on the face or balding scalp.
American Regent is conducting a voluntary nationwide recall of one lot of calcium gluconate injection 10% because some of the vials may contain silicone particles.
Sanuwave Health announced positive results from its Phase 3 study of dermaPACE for the treatment of diabetic foot ulcers.
Fibrocell Science announced that the FDA has approved laVív (azficel-T) for the improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults.
Bristol-Myers Squibb informed healthcare professionals about the Risk Evaluation and Mitigation Strategy (REMS), developed in collaboration with the FDA, that is required to ensure that the benefits of Yervoy (ipilimumab) outweigh the risks of severe and fatal immune-mediated adverse reactions.
Kythera Biopharmaceuticals presented additional efficacy data from a Phase 2b study evaluating ATX-101 for the reduction of submental fat.
SkinMedica has launched Redness Relief CalmPlex to reduce visible redness of the skin.